Public-registry site landscape for NCT04489511, a Stargardt Disease-1 study sponsored by Stargazer Pharmaceuticals, Inc.. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT04489511 (registry record) |
| Sponsor | Stargazer Pharmaceuticals, Inc. |
| Condition(s) | Stargardt Disease-1 |
| Phase | PHASE2 |
| Listed sites | 5 |
| Site countries | United States |
Eichor generates a preliminary site-risk snapshot for NCT04489511 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →